Moderna wants to harness human cells to become tiny vaccine factories.
The race to develop vaccine for the coronavirus is not only shifting into high gear. It turns out, drug companies are following different maps to find the finish line. FULL STORY: ABC7 wants to help make the Bay Area an…
Moderna announced Monday it had received an additional $472 million from the U.S. government to support the company’s late-stage development of its vaccine including the phase three study, which began Monday and will include more than 30,000 participants. Moderna CEO…
Angela Rasmussen, PhD, explains how preliminary findings for both candidates define their potential for preventing or lessening coronavirus.
Deputy Chief Medical Officer Professor Michael Kidd discusses the recently released trial results of a potential COVID-19 vaccine by US company Moderna, the coronavirus cluster in Sydney and concerns over aged care outbreaks in Victoria. Subscribe: Get more breaking news…
Covid 19 vaccine shows promising immune response results
